Immatics NV
NASDAQ:IMTX
Immatics NV
NASDAQ:IMTX
Price:
10.81 USD
8.86%
Updated:
May 2, 2024
Immatics NV
Cash from Operating Activities
|
Immatics NV
Cash from Operating Activities Peer Comparison
Comparables:
BNTX
MOR
CVAC
BIO
FYB
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Immatics NV
NASDAQ:IMTX
|
Cash from Operating Activities
€18.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Cash from Operating Activities
€5.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MorphoSys AG
XETRA:MOR
|
Cash from Operating Activities
-€295.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
|
CureVac NV
NASDAQ:CVAC
|
Cash from Operating Activities
-€267.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Cash from Operating Activities
-€2.7m
|
CAGR 3-Years
46%
|
CAGR 5-Years
44%
|
CAGR 10-Years
9%
|
|
|
Formycon AG
XETRA:FYB
|
Cash from Operating Activities
-€18.9m
|
CAGR 3-Years
-134%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
See Also
What is Immatics NV's Cash from Operating Activities?
Cash from Operating Activities
18.2m
EUR
18.2m
EUR
Based on the financial report for Dec 31, 2023, Immatics NV's Cash from Operating Activities amounts to 18.2m EUR.
What is Immatics NV's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-3%
-3%
Over the last year, the Cash from Operating Activities growth was -82%.
You don't have any saved screeners yet
